OTCM
FLHLF
Market cap26kUSD
Apr 22, Last price
0.00USD
Name
Filament Health Corp
Chart & Performance
P/E
—
P/S
0.06
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
617k
-71.06%
Net income
-5m
L-6.61%
CFO
-2m
L-45.34%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Filament Health Corp. is a pioneering company dedicated to the discovery and extraction of natural psychedelic compounds. Its operations encompass the cultivation of psychedelic plants, genetic research, advanced extraction methodologies, and the conduct of internal clinical trials. Furthermore, the firm licenses its intellectual property and potential drug substances to pharmaceutical developers, scientific researchers, and other authorized entities. The company's principal office is located in Vancouver, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | |||||
Revenues | |||||
Cost of revenue | |||||
Unusual Expense (Income) | |||||
NOPBT | |||||
NOPBT Margin | |||||
Operating Taxes | |||||
Tax Rate | |||||
NOPAT | |||||
Net income | |||||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | |||||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | |||||
| Cash flow | |||||
Cash from operating activities | |||||
CAPEX | |||||
Cash from investing activities | |||||
Cash from financing activities | |||||
FCF | |||||
| Balance | |||||
Cash | |||||
Long term investments | |||||
Excess cash | |||||
Stockholders' equity | |||||
Invested Capital | |||||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | |||||
Price | |||||
Market cap | |||||
EV | |||||
EBITDA | |||||
EV/EBITDA | |||||
Interest | |||||
Interest/NOPBT | |||||